Myra Vision

Campbell, United States Founded: 2019 • Age: 7 yrs
Nanotechnology-based devices for glaucoma treatment are developed.

About Myra Vision

Myra Vision is a Healthcare company based in Campbell (United States) founded in 2019. Nanotechnology-based devices for glaucoma treatment are developed. Myra Vision has raised $42 million across 2 funding rounds from investors including PA MedTech VC Fund, Cormorant and Capital Partnership. Its chief executive, as recorded, is Robert Chang. Myra Vision offers products and services including Calibreye TGT Surgical System. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is Myra Vision Inc. Its competitors include Glaukos, Ivantis and Transcend Medical; 3 of its 3 listed competitors have raised funding.

Company details

Myra Vision was founded in 2019 and is based in Campbell, United States. A medical device utilizing nanotechnology is developed for glaucoma management in the healthcare sector. Intraocular pressure is reduced by the device to address moderate to severe cases. Operations center on device innovation, with leadership provided by CEO Robert Chang. The domain myravision.com is maintained for company information.

  • Headquarters Campbell, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website myravision.com
  • Social LinkedIn
  • Legal Name Myra Vision Inc
Operational Areas
Key Metrics
  • Total Equity Funding
    $42M (USD)

    in 2 rounds

  • Latest Funding Round
    $25M (USD), Series B

    Jun 2023

  • Investors
    Cormorant

    & 5 more

Products & Services of Myra Vision

Myra Vision offers a comprehensive portfolio of products and services, including Calibreye TGT Surgical System.

Calibreye TGT Surgical System
Surgical Device

Adjustable system for controlling intraocular pressure in glaucoma patients.

Funding Insights of Myra Vision

Myra Vision has successfully raised a total of $42M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $42M
  • Total Rounds 2
  • Last Round Series B β€” $25M
  • First Round $17M

    (Jun 2021)

  • Investors Count 6

All 2 funding rounds of Myra Vision with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2023$25MSeries B–PA MedTech VC Fund, Cormorant Asset Management
Jun 2021$17MSeries A–The Capital Partnership
Valuation history

6 investors in total: 6 institutional.

Investors in Myra Vision

Myra Vision has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include PA MedTech VC Fund, Cormorant and Capital Partnership.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
An asset management and investment platform is operated by The Capital Partnership.
tcpam.comLondon, United Kingdom
Medical technology innovation hub focused on device development in Silicon Valley.
2001shifamed.com
Manages diversified investment portfolios across various asset classes.
1997cormorant.comBoston, United States
Sourcing and deploying capital for real estate investments and developments.
cormorant-capital.comNew York, United States
Real estate consulting services are provided by Capital Partnership.
capital-partnership.co.jpTokyo, Japan
Premium access

Investor details for Myra Vision

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Myra Vision

9 people are tracked at Myra Vision (5 in leadership, 4 in team).

NameRoleGroup
Robert Chang
CEOLeadership
Signe Erickson
Chief Operating OfficerLeadership
Brock Gause
Director Of OperationsLeadership
Claudio Argento
CTO - Co-FounderLeadership
Rick Iribarren
Senior Director Of OperationsLeadership
Katherine Sapozhnikov
Senior R&D EngineerTeam
Nicholas Dubil
Associate Production EngineerTeam
Michael Heck
Senior Process Development EngineerTeam
Abigail Brazil
Research And Development EngineerTeam
Premium access

Complete people profiles for Myra Vision

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Myra Vision

3 dated milestones of Myra Vision across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Myra Vision is founded.
  2. Funding First funding round of $17.0M.
  3. Funding Latest funding round, Series B, of $25.0M.

Competitors of Myra Vision

Myra Vision has 3 listed competitors in our database, 3 of them funded. They include Glaukos, Ivantis and Transcend Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
glaukos.com2001Laguna Hills, United States$117.57M907
Developer of implants to treat glaucoma
ivantisinc.com2007Irvine, United States$166.23M132
Implantable device to relieve intraocular pressure in open angle glaucoma
transcendmedical.com2006Menlo Park, United States$122.27M20
Minimally invasive glaucoma stents are developed to enhance aqueous outflow.
Premium access

Detailed competitors of Myra Vision

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Ophthalmology

3 companies that operate in the same segment as Myra Vision (Ophthalmology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of a wide range of eye care products
1945Fort Worth, Texas, United StatesUSD 171.61 MUSD 24.69 B25,941
Genetic medicines are developed by 4DMT for transformative therapies.
2013Emeryville, California, United StatesUSD 186.59 MUSD 85.21 M227
Developer of antibodies to treat complement-mediated neurodegenerative diseases
2011San Francisco, California, United StatesUSD 256 M100
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Myra Vision

Premium access

Complete news archive for Myra Vision

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Myra Vision

Myra Vision was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Myra Vision is headquartered in Campbell, United States. It is registered at Campbell, California, United States.

Robert Chang is the CEO of Myra Vision, as recorded in our data.

Myra Vision is a funded company, having raised a total of $42M across 2 funding rounds to date. The company's 1st funding round was a Series A of $17M, raised on Jun 2021.

Myra Vision was founded in 2019 and is based in Campbell, United States. A medical device utilizing nanotechnology is developed for glaucoma management in the healthcare sector. Intraocular pressure is reduced by the device to address moderate to severe cases. Operations center on device innovation, with leadership provided by CEO Robert Chang. The domain myravision.com is maintained for company information.

Myra Vision's top competitors include Glaukos, Ivantis and Transcend Medical.

Myra Vision offers Calibreye TGT Surgical System.

Myra Vision has 6 investors. Key investors include PA MedTech VC Fund, Cormorant, Capital Partnership, The Capital Partnership, and Shifamed.

Myra Vision operates through Myra Vision Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available